Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Prostatic Neoplasms 3Breast Neoplasms 3Neoplasms 2Melanoma 2Breast Neoplasms, Male 2Rectal Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Lung Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Leukemia 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 166Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 84Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × saponin QA-21V1 × Clear all
NCT00470574 2020-11-18

Vaccine Therapy and QS21 in Treating Patients With Metastatic Breast Cancer

Memorial Sloan Kettering Cancer Center

Phase NA Completed
7 enrolled 7 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00030823 2015-12-30

Vaccine Therapy in Treating Patients at High Risk for Breast Cancer Recurrence

Memorial Sloan Kettering Cancer Center

Phase NA Completed
14 enrolled 6 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00003357 2012-12-13

Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
9 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡